agilon health (AGL) Stock Forecast, Price Target & Predictions
AGL Stock Forecast
agilon health stock forecast is as follows: an average price target of $4.40 (represents a 163.47% upside from AGL’s last price of $1.67) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.
AGL Price Target
The average price target for agilon health (AGL) is $4.40 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $6.50 to $2.50. This represents a potential 163.47% upside from AGL's last price of $1.67.
AGL Analyst Ratings
According to 13 Wall Street analysts, agilon health's rating consensus is 'Buy'. The analyst rating breakdown for AGL stock is 0 'Strong Buy' (0.00%), 6 'Buy' (46.15%), 6 'Hold' (46.15%), 1 'Sell' (7.69%), and 0 'Strong Sell' (0.00%).
agilon health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 29, 2024 | Daniel Grosslight | Citigroup | $2.50 | $2.52 | -0.79% | 49.70% |
| Oct 02, 2024 | Adam Ron | Bank of America Securities | $3.00 | $3.54 | -15.13% | 79.64% |
| Aug 08, 2024 | George Hill | Deutsche Bank | $4.00 | $5.60 | -28.57% | 139.52% |
| May 29, 2024 | Michael Ha | Robert W. Baird | $6.00 | $5.76 | 4.17% | 259.28% |
| May 24, 2024 | Jailendra Singh | Truist Financial | $6.50 | $5.65 | 15.04% | 289.22% |
| Jul 26, 2022 | David MacDonald | Truist Financial | $33.00 | $25.13 | 31.32% | 1876.05% |
The latest agilon health stock forecast, released on Oct 29, 2024 by Daniel Grosslight from Citigroup, set a price target of $2.50, which represents a -0.79% decrease from the stock price at the time of the forecast ($2.52), and a 49.70% increase from AGL last price ($1.67).
agilon health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 5 |
| Avg Price Target | $2.50 | $2.75 | $4.40 |
| Last Closing Price | $1.67 | $1.67 | $1.67 |
| Upside/Downside | 49.70% | 64.67% | 163.47% |
In the current month, the average price target of agilon health stock is $2.50, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 49.70% increase as opposed to agilon health's last price of $1.67. This month's average price target is down -9.09% compared to last quarter, and down -43.18% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 11, 2024 | JMP Securities | - | Perform | Downgrade |
| Nov 08, 2024 | William Blair | - | Market Perform | Downgrade |
| Oct 29, 2024 | Citigroup | Buy | Sell | Downgrade |
| Oct 02, 2024 | RBC Capital | Buy | Buy | Hold |
| Oct 02, 2024 | Evercore ISI | Underperform | Underperform | Hold |
| Aug 08, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Aug 05, 2024 | Cowen & Co. | Hold | Hold | Hold |
| May 08, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Oct 20, 2023 | BNP Paribas | - | Neutral | Initialise |
| Oct 20, 2023 | Benchmark | - | Buy | Initialise |
agilon health's last stock rating was published by JMP Securities on Nov 11, 2024. The company Downgrade its AGL rating from "null" to "Perform".
agilon health Financial Forecast
agilon health Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.06B | $1.22B | $1.15B | $1.14B | $689.77M | $694.86M | $670.13M | $653.45M | $462.89M | $458.61M | $498.96M | $413.10M |
| Avg Forecast | $1.99B | $1.94B | $1.96B | $2.01B | $1.70B | $1.64B | $1.67B | $1.75B | $1.50B | $1.47B | $1.54B | $1.61B | $1.04B | $1.13B | $1.11B | $1.08B | $662.01M | $662.21M | $647.79M | $642.87M | $452.95M | $450.52M | $473.20M | $405.86M |
| High Forecast | $2.16B | $2.10B | $2.13B | $2.18B | $1.84B | $1.78B | $1.81B | $1.99B | $1.52B | $1.48B | $1.55B | $1.61B | $1.06B | $1.13B | $1.20B | $1.17B | $718.98M | $662.21M | $647.79M | $642.87M | $452.95M | $450.52M | $473.20M | $405.86M |
| Low Forecast | $1.86B | $1.81B | $1.84B | $1.88B | $1.58B | $1.53B | $1.56B | $1.54B | $1.47B | $1.46B | $1.53B | $1.61B | $1.02B | $1.13B | $1.04B | $1.01B | $618.27M | $662.21M | $647.79M | $642.87M | $452.95M | $450.52M | $473.20M | $405.86M |
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.07% | 1.04% | 1.05% | 1.04% | 1.05% | 1.03% | 1.02% | 1.02% | 1.02% | 1.05% | 1.02% |
agilon health's average Quarter revenue forecast for Mar 24 based on 9 analysts is $1.61B, with a low forecast of $1.61B, and a high forecast of $1.61B. AGL's average Quarter revenue forecast represents a 52.76% increase compared to the company's last Quarter revenue of $1.06B (Dec 23).
agilon health EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-228.01M | $-29.03M | $-13.94M | $20.11M | $-62.22M | $-25.49M | $-11.01M | $4.90M | $-57.62M | $-30.78M | $-293.30M | $-8.64M |
| Avg Forecast | $-154.85M | $-150.48M | $-152.73M | $-156.18M | $-131.79M | $-127.47M | $-129.79M | $-135.91M | $-116.88M | $-114.31M | $-119.82M | $-125.39M | $-80.55M | $-88.20M | $-86.20M | $-83.78M | $-51.46M | $-54.00M | $-8.85M | $-52.42M | $-36.94M | $-36.74M | $-38.59M | $-6.81M |
| High Forecast | $-144.62M | $-140.54M | $-142.64M | $-145.86M | $-123.09M | $-119.04M | $-121.21M | $-119.97M | $-114.54M | $-113.44M | $-119.13M | $-125.39M | $-79.02M | $-88.19M | $-80.50M | $-78.24M | $-48.06M | $-54.00M | $-7.08M | $-52.42M | $-36.94M | $-36.74M | $-38.59M | $-5.45M |
| Low Forecast | $-168.18M | $-163.43M | $-165.87M | $-169.62M | $-143.13M | $-138.44M | $-140.96M | $-154.90M | $-118.44M | $-115.18M | $-120.52M | $-125.39M | $-82.09M | $-88.20M | $-93.62M | $-90.99M | $-55.88M | $-54.00M | $-10.61M | $-52.42M | $-36.94M | $-36.74M | $-38.59M | $-8.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.83% | 0.33% | 0.16% | -0.24% | 1.21% | 0.47% | 1.25% | -0.09% | 1.56% | 0.84% | 7.60% | 1.27% |
9 analysts predict AGL's average Quarter EBITDA for Jun 23 to be $-86.20M, with a high of $-80.50M and a low of $-93.62M. This is -528.65% lower than agilon health's previous annual EBITDA (Mar 23) of $20.11M.
agilon health Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-230.48M | $-31.48M | $-16.80M | $16.02M | $-56.05M | $-30.50M | $-21.04M | $726.00K | $-57.07M | $-35.84M | $-298.85M | $-15.08M |
| Avg Forecast | $-30.59M | $-5.02M | $-23.59M | $-17.19M | $-58.45M | $-66.18M | $-27.64M | $-13.62M | $-86.90M | $-40.58M | $-28.94M | $-5.21M | $-114.00M | $-22.36M | $-7.52M | $14.41M | $-39.98M | $-18.54M | $-11.36M | $-249.64K | $-43.38M | $-34.96M | $-21.83M | $-11.88M |
| High Forecast | $-27.96M | $-4.59M | $-21.56M | $-15.71M | $-53.43M | $-60.50M | $-25.26M | $5.45M | $-52.14M | $-37.09M | $-26.45M | $-4.76M | $-61.07M | $-20.44M | $-6.87M | $16.02M | $-36.55M | $-18.54M | $-9.09M | $-249.64K | $-43.38M | $-34.96M | $-21.83M | $-9.50M |
| Low Forecast | $-34.01M | $-5.58M | $-26.23M | $-19.11M | $-64.99M | $-73.58M | $-30.73M | $-27.23M | $-117.31M | $-45.12M | $-32.17M | $-5.79M | $-138.43M | $-24.87M | $-8.36M | $13.17M | $-44.46M | $-18.54M | $-13.63M | $-249.64K | $-43.38M | $-34.96M | $-21.83M | $-14.26M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.02% | 1.41% | 2.23% | 1.11% | 1.40% | 1.65% | 1.85% | -2.91% | 1.32% | 1.03% | 13.69% | 1.27% |
agilon health's average Quarter net income forecast for Jun 23 is $-7.52M, with a range of $-8.36M to $-6.87M. AGL's average Quarter net income forecast represents a -146.91% decrease compared to the company's last Quarter net income of $16.02M (Mar 23).
agilon health SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $64.70M | $74.14M | $81.50M | $66.66M | $75.21M | $51.98M | $51.92M | $39.83M | $53.84M | $46.64M | $317.56M | $37.78M |
| Avg Forecast | $264.16M | $256.70M | $260.53M | $266.42M | $224.82M | $217.44M | $221.40M | $231.85M | $199.38M | $195.00M | $204.40M | $213.90M | $137.41M | $150.45M | $147.05M | $142.91M | $87.78M | $87.80M | $28.56M | $85.23M | $60.05M | $59.73M | $62.74M | $29.76M |
| High Forecast | $286.89M | $278.79M | $282.95M | $289.35M | $244.17M | $236.15M | $240.46M | $264.23M | $202.04M | $196.47M | $205.59M | $213.90M | $140.03M | $150.46M | $159.70M | $155.21M | $95.33M | $87.80M | $34.27M | $85.23M | $60.05M | $59.73M | $62.74M | $35.72M |
| Low Forecast | $246.70M | $239.74M | $243.32M | $248.82M | $209.97M | $203.07M | $206.77M | $204.65M | $195.39M | $193.52M | $203.22M | $213.90M | $134.80M | $150.45M | $137.33M | $133.47M | $81.98M | $87.80M | $22.85M | $85.23M | $60.05M | $59.73M | $62.74M | $23.81M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.49% | 0.55% | 0.47% | 0.86% | 0.59% | 1.82% | 0.47% | 0.90% | 0.78% | 5.06% | 1.27% |
agilon health's average Quarter SG&A projection for Mar 24 is $213.90M, based on 9 Wall Street analysts, with a range of $213.90M to $213.90M. The forecast indicates a 230.63% rise compared to AGL last annual SG&A of $64.70M (Dec 23).
agilon health EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.57 | $-0.08 | $-0.04 | $0.04 | $-0.14 | $-0.07 | $-0.05 | - | $-0.14 | $-0.09 | $-0.79 | $-0.04 |
| Avg Forecast | $-0.07 | $-0.01 | $-0.06 | $-0.04 | $-0.14 | $-0.16 | $-0.07 | $-0.03 | $-0.21 | $-0.10 | $-0.07 | $-0.01 | $-0.28 | $-0.05 | $-0.02 | $0.04 | $-0.10 | $-0.05 | $-0.02 | $-0.00 | $-0.11 | $-0.09 | $-0.05 | $-0.03 |
| High Forecast | $-0.07 | $-0.01 | $-0.05 | $-0.04 | $-0.13 | $-0.15 | $-0.06 | $0.01 | $-0.13 | $-0.09 | $-0.06 | $-0.01 | $-0.15 | $-0.05 | $-0.02 | $0.04 | $-0.09 | $-0.05 | $-0.02 | $-0.00 | $-0.11 | $-0.09 | $-0.05 | $-0.03 |
| Low Forecast | $-0.08 | $-0.01 | $-0.06 | $-0.05 | $-0.16 | $-0.18 | $-0.07 | $-0.07 | $-0.29 | $-0.11 | $-0.08 | $-0.01 | $-0.34 | $-0.06 | $-0.02 | $0.03 | $-0.11 | $-0.05 | $-0.02 | $-0.00 | $-0.11 | $-0.09 | $-0.05 | $-0.03 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.06% | 1.43% | 2.24% | 1.14% | 1.44% | 1.65% | 3.08% | -2.97% | 1.33% | 1.06% | 14.88% | 1.32% |
According to 9 Wall Street analysts, agilon health's projected average Quarter EPS for Jun 23 is $-0.02, with a low estimate of $-0.02 and a high estimate of $-0.02. This represents a -145.66% decrease compared to AGL previous annual EPS of $0.04 (Mar 23).
agilon health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AGL | agilon health | $1.67 | $4.40 | 163.47% | Buy |
| ACHC | Acadia Healthcare Company | $39.10 | $82.33 | 110.56% | Buy |
| SGRY | Surgery Partners | $22.51 | $40.80 | 81.25% | Buy |
| AMED | Amedisys | $90.00 | $143.38 | 59.31% | Hold |
| HCSG | Healthcare Services Group | $11.39 | $17.33 | 52.15% | Hold |
| MODV | ModivCare | $16.31 | $24.50 | 50.21% | Buy |
| INNV | InnovAge | $4.70 | $6.80 | 44.68% | Hold |
| EHAB | Enhabit | $7.46 | $10.25 | 37.40% | Hold |
| PNTG | Pennant Group | $30.78 | $34.67 | 12.64% | Buy |
| ADUS | Addus HomeCare | $120.99 | $132.80 | 9.76% | Buy |
| UHS | Universal Health Services | $197.52 | $208.47 | 5.54% | Hold |
| ENSG | Ensign Group | $144.66 | $148.20 | 2.45% | Buy |
| EHC | Encompass Health | $98.93 | $97.00 | -1.95% | Buy |